Open Surgery
0
Pipeline Programs
1
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Medical MicroinstrumentsItaly - Pisa
3 programsSymani Surgical SystemN/A1 trial
Symani Surgical SystemN/A1 trial
Symani Surgical SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Medical MicroinstrumentsSymani Surgical System
Medical MicroinstrumentsSymani Surgical System
Medical MicroinstrumentsSymani Surgical System
Clinical Trials (3)
Total enrollment: 882 patients across 3 trials
A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
Start: Sep 2025Est. completion: Dec 2027455 patients
N/ARecruiting
A Global, Prospective, Real-World, Investigation of the Symani® Surgical System for Microsurgical Anastomosis
Start: Feb 2025Est. completion: Feb 20300
N/AWithdrawn
PRIMO Post-Market Clinical Follow Up Study
Start: Apr 2021Est. completion: Jul 2025427 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 882 patients
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.